Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH2-terminus in type 2-diabetic patients and in healthy subjects - Deacon, C F; Nauck, M A; Toft-Nielsen, M (Diabetes, 1995)
et al.